Study Looking at Biomarkers in Ovarian Cancer

What this study is about

This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of the testing done on the samples will be given to the participant's treating physician who may use the information to guide treatment decisions.

Who can join (things the study team will check)

✅ You may be able to join if…

• Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
• Must be 18 years of age or older.
• Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
• Have a life expectancy greater than or equal to 6 months.
• Able to provide adequate informed consent.
• Willing to undergo blood or fluid collection and tumour biopsy
• Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study.
• Archival tissue must be available for patients that are enrolled at the time of progression.

🚫 You may not be able to join if…

• Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
• Must not have other tumour histology other than high grade serous.
• Must not have contraindication to tumour biopsy and/or blood sampling.

Where this trial is running

• Royal Victoria Regional Health Centre, Barrie, Ontario, Canada
• Juravinski Cancer Centre, Hamilton, Ontario, Canada
• Kingston Health Sciences Centre, Kingston, Ontario, Canada
• London Health Sciences Centre, London, Ontario, Canada
• The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
• Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
• Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Who to contact

Amit Oza, M.D. · 416-946-2818 · amit.oza@uhn.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT03419689.